Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature

• Publication date

  2014-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature13862PMID 25337873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells

  2013cited by this paper
• Intravital analysis of vascular permeability in mice using two-photon microscopy

  2013cited by this paper
• The UCSC Cancer Genomics Browser: update 2013

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway.

  2012cited by this paper
• If You Don’t Look, You Won’t See: Intravital Multiphoton Imaging of Primary and Metastatic Breast Cancer

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• High-resolution multiphoton imaging of tumors in vivo.

  2011cited by this paper
• Hallmarks of cancer: interactions with the tumor stroma.

  2010cited by this paper
• Tumor-host interactions: a far-reaching relationship.

  2010cited by this paper
• Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone*

  2009cited by this paper
• Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

  2009cited by this paper
• A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

  2009cited by this paper
• The UCSC Cancer Genomics Browser

  2009cited by this paper
• Chemokine Networks and Breast Cancer Metastasis

  2007cited by this paper
• Oestrogen receptor negative breast cancers exhibit high cytokine content

  2007cited by this paper
• Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.

  2005cited by this paper
• Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

  2003cited by this paper
• Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

  2003cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma

  2001cited by this paper
• Real-time quantitative PCR.

  2001cited by this paper
• Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants

  2000cited by this paper
• Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

  2000cited by this paper
• Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1

  1999cited by this paper
• Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer.

  1998cited by this paper
• Prognostic factors in inflammatory breast cancer and therapeutic implications.

  1994cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper
• Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types

  year unknowncited by this paper

• Unpacking the lipid-immune axis in health and disease.

  2026cites this paper
• Spatiotemporal dynamics of radioresistance: decoding macrophage-driven radioprotective niches through temporal-spatial reprogramming.

  2026cites this paper
• Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

  2026cites this paper
• Macrophages: Targets for next-generation cancer immunotherapy.

  2026cites this paper
• Leveraging macrophage plasticity for precision-targeted tumor immunotherapy.

  2026cites this paper
• HOXA10 drives immune evasion in early lung adenocarcinoma by recruiting immunosuppressive macrophages via NF-κB/CCL2 signaling.

  2026cites this paper
• Tumor‐Intrinsic Forkhead Box A2 Regulates the Lymph Node Metastasis of Papillary Thyroid Carcinoma by Regulating T‐Cell Apoptosis

  2026cites this paper
• Chemokine ligand 2: beyond chemotaxis—a multifaceted role in tumor progression

  2025cites this paper
• Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer

  2025cites this paper
• Distinct Roles of Monocyte Subsets in Cancer

  2025cites this paper
• Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer.

  2025cites this paper
• CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review)

  2025cites this paper
• Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells.

  2025cites this paper
• MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer

  2025cites this paper
• Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

  2025cites this paper
• Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets

  2025cites this paper
• Unveiling the link between chronic inflammation and cancer

  2025cites this paper
• Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer

  2025cites this paper
• Recent advancements in lung cancer research: a narrative review

  2025cites this paper
• Tumor Microenvironment On‐A‐Chip and Single‐Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression

  2025cites this paper
• Adipokines in Breast Cancer: Decoding Genetic and Proteomic Mechanisms Underlying Migration, Invasion, and Proliferation

  2025cites this paper
• Sepsis: the evolution of molecular pathogenesis concepts and clinical management

  2025cites this paper
• A new concept for oncogenic analysis of tumor microenvironment and chemokines and non-coding RNAs in breast cancer

  2025cites this paper
• Cancer Reversion Therapy: Prospects, Progress and Future Directions

  2025cites this paper
• High expression of formin-2 can promote ovarian cancer chemoresistance via immunosuppressive macrophages

  2025cites this paper
• DAPK1-positve macrophages facilitate immunosuppressive microenvironment and determine immunotherapy efficacy in colorectal cancer

  2025cites this paper
• Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions

  2025cites this paper
• Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy

  2025cites this paper
• CircRHBDD1(4,5)/CCL2 mRNA interaction promotes breast cancer bone metastasis via bone metastatic niche formation.

  2025cites this paper
• Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

  2025cites this paper
• RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release

  2025cites this paper
• Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche

  2025cites this paper
• A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors.

  2025cites this paper
• The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis.

  2025cites this paper
• Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway

  2025cites this paper
• Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches

  2025cites this paper
• Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming

  2025cites this paper
• DPP7 promotes fatty acid β-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer

  2025cites this paper
• Macrophage-centered therapy strategies: a promising weapon in cancer immunotherapy

  2025cites this paper
• GuBenPeiYuan Formula Inhibits Lung Cancer Metastasis by Suppressing Myeloid-Derived Suppressor Cells and Related Immune Cells

  2025cites this paper
• Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment

  2025cites this paper
• Gold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration

  2025cites this paper
• Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

  2025cites this paper
• Understanding the Dual Role of Macrophages in Tumor Growth and Therapy: A Mechanistic Review

  2025cites this paper
• Targeting Myeloid Cells for Cancer Immunotherapy

  2025cites this paper
• Progress in targeting tumor-associated macrophages in cancer immunotherapy

  2025cites this paper
• Silibinin Anticancer Effects Through the Modulation of the Tumor Immune Microenvironment in Triple-Negative Breast Cancer

  2025cites this paper
• Roles of tumor-associated macrophages in triple-negative breast cancer progression

  2025cites this paper
• Immune cell changes following chemotherapy in advanced pancreatic cancer with variations based on gender

  2025cites this paper
• ATM promotes bone metastatic propensity of breast cancer by inducing osteoclastogenesis via the NFκB-CCL2 pathway.

  2025cites this paper
• Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers

  2025cites this paper
• Role of chemokines in aging and age-related diseases.

  2024cites this paper
• Leptin/LPS-treated dendritic cells reduce the expression of genes involved in tumor tissue metastasis and angiogenesis in an animal model of breast cancer

  2024cites this paper
• The role of macrophage migratory behavior in development, homeostasis and tumor invasion

  2024cites this paper
• Matairesinol repolarizes M2 macrophages to M1 phenotype to induce apoptosis in triple-negative breast cancer cells

  2024cites this paper
• Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis

  2024cites this paper
• CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis

  2024cites this paper
• Roles of Chemokine Axes in Breast Cancer.

  2024cites this paper
• Circulating Interleukin-6 Mediates PM2.5-Induced Ovarian Injury by Suppressing the PPARγ Pathway

  2024cites this paper
• Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology

  2024cites this paper
• Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity

  2024cites this paper
• The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets

  2024cites this paper
• Dissecting the emerging role of cancer-associated adipocyte-derived cytokines in remodeling breast cancer progression

  2024cites this paper
• Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis.

  2024cites this paper
• Emerging immunologic approaches as cancer anti-angiogenic therapies

  2024cites this paper
• CCL2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor models

  2024cites this paper
• Bifunctionality and Antitumor Efficacy of ZG-126, a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule

  2024cites this paper
• An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls

  2024cites this paper
• The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

  2024cites this paper
• CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis

  2024cites this paper
• The temporal progression of lung immune remodeling during breast cancer metastasis.

  2024cites this paper
• PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC

  2024cites this paper
• Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer

  2024cites this paper
• Macrophages as targets in hepatocellular carcinoma therapy.

  2024cites this paper
• Fatty acid metabolism of immune cells: a new target of tumour immunotherapy

  2024cites this paper
• Fibroblasts: invigorated targets in pre-metastatic niche formation

  2024cites this paper
• The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review

  2024cites this paper
• S6K1 deficiency in tumor stroma impairs lung metastasis of melanoma in mice.

  2024cites this paper
• From monocyte‐derived macrophages to resident macrophages—how metabolism leads their way in cancer

  2024cites this paper
• DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy

  2024cites this paper
• Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling

  2024cites this paper
• Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Discovery of a CCR2-targeting pepducin therapy for chronic pain.

  2024cites this paper
• Clinical landscape of macrophage-reprogramming cancer immunotherapies

  2024cites this paper
• Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

  2024cites this paper
• Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

  2024cites this paper
• The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis

  2024cites this paper
• Harmonizing hope: navigating the osteoarthritis melody through the CCL2/CCR2 axis for innovative therapeutic avenues

  2024cites this paper
• Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

  2024cites this paper
• Small extracellular vesicles derived from mesenchymal stem/stromal cells as drug-delivery tools for anti-cancer drugs

  2024cites this paper
• Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer

  2024cites this paper
• Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells

  2023cites this paper
• Emerging role of interactions between tumor angiogenesis and cancer stem cells.

  2023cites this paper
• Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy

  2023cites this paper
• MCP‐1 expression in breast cancer and its association with distant relapse

  2023cites this paper
• The elusive Luminal B breast cancer and the mysterious chemokines

  2023cites this paper
• Liver resection modulates hepatic chemokine levels in breast cancer.

  2023cites this paper
• PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer

  2023cites this paper
• Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages

  2023cites this paper
• CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice

  2023cites this paper